MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in CIT, encoding citron rho-interacting serine/threonine kinase, cause severe primary microcephaly in humans.
|
27503289 |
2016 |
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Biallelic Mutations in Citron Kinase Link Mitotic Cytokinesis to Human Primary Microcephaly.
|
27453578 |
2016 |
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in Citron Kinase Cause Recessive Microlissencephaly with Multinucleated Neurons.
|
27453579 |
2016 |
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic Mutations in Citron Kinase Link Mitotic Cytokinesis to Human Primary Microcephaly.
|
27453578 |
2016 |
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
CIT, a gene involved in neurogenic cytokinesis, is mutated in human primary microcephaly.
|
27519304 |
2016 |
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autosomal Recessive Primary Microcephaly
|
0.400 |
GermlineCausalMutation
|
disease |
ORPHANET |
Biallelic Mutations in Citron Kinase Link Mitotic Cytokinesis to Human Primary Microcephaly.
|
27453578 |
2016 |
Autosomal Recessive Primary Microcephaly
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Microcephaly
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in microcephaly.
|
29343805 |
2018 |
Microcephaly
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Moreover, CIT-K mutations have recently been linked to the development of human microcephaly, and CIT-K has been identified as a potential target in cancer therapy.
|
28468989 |
2017 |
Microcephaly
|
0.320 |
Biomarker
|
disease |
RGD |
Characterization of seizures in the flathead rat: a new genetic model of epilepsy in early postnatal development.
|
10219263 |
1999 |
Microcephaly
|
0.320 |
Biomarker
|
disease |
HPO |
|
|
|
MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic Mutations in Citron Kinase Link Mitotic Cytokinesis to Human Primary Microcephaly.
|
27453578 |
2016 |
Primary microcephaly
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Visual seizure
|
0.200 |
Biomarker
|
disease |
RGD |
Characterization of seizures in the flathead rat: a new genetic model of epilepsy in early postnatal development.
|
10219263 |
1999 |
Failure to Thrive
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Two consanguineous families segregating the phenotype of severe primary microcephaly, spasticity and failure to thrive had overlapping autozygomes in which exome sequencing identified homozygous splicing variants in CIT that segregate with the phenotype within each family.
|
27503289 |
2016 |
Muscle Spasticity
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Two consanguineous families segregating the phenotype of severe primary microcephaly, spasticity and failure to thrive had overlapping autozygomes in which exome sequencing identified homozygous splicing variants in CIT that segregate with the phenotype within each family.
|
27503289 |
2016 |
Failure to Thrive
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Spasticity
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Parkinson Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A53T SNCA carriers with Parkinson's disease showed a loss of striatal [<sup>123</sup>I]FP-CIT-specific binding ratio compared with healthy controls (p<0·0001).
|
31229470 |
2019 |
Parkinson Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The utility of the combined use of <sup>123</sup>I-FP-CIT SPECT and neuromelanin MRI in differentiating Parkinson's disease from other parkinsonian syndromes.
|
29804474 |
2019 |
Parkinson Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
F-FP-CIT PET and MRI are not helpful in distinguishing CBD from idiopathic Parkinson disease.
|
30371594 |
2019 |
Parkinson Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Semiquantitative <sup>123</sup>I-FP-CIT SPECT striatal evaluation combined with SVM represents a promising approach to disentangle PD from non-degenerative conditions and from atypical PS at the early stage.
|
31037416 |
2019 |